Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
56,978,507
-
Share change
-
+4,751,060
-
Total reported value
-
$799,748,914
-
Put/Call ratio
-
15%
-
Price per share
-
$14.04
-
Number of holders
-
258
-
Value change
-
+$66,260,391
-
Number of buys
-
117
-
Number of sells
-
119
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2022
As of 30 Jun 2022 TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) had 258 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 56,978,507 shares of stock of the company.
Largest 10 holders included Mondrian Investment Partners LTD, MORGAN STANLEY, MACQUARIE GROUP LTD, GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, BlackRock Inc., BRANDES INVESTMENT PARTNERS, LP, VAN ECK ASSOCIATES CORP, and FMR LLC.
This table shows 258 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.